Mark B. Chandler
Chairman at Biophysical Corp.
Profile
Mark B.
Chandler was the founder of Luminex Corp.
(founded in 1995), Myriad RBM, Inc. (founded in 2002), and Inland Laboratories, Inc. (founded in 1982), where he held the titles of Chairman, President & Chief Executive Officer, and Director, respectively.
Currently, he holds the position of Chairman at Biophysical Corp.
since 2004 and Director at The EastWest Institute.
Dr. Chandler received his doctorate degree from The University of Texas at Austin in 1981.
Mark B. Chandler active positions
| Companies | Position | Start |
|---|---|---|
Biophysical Corp.
 Biophysical Corp. BiotechnologyHealth Technology Biophysical Corp. develops, manages and markets biomarker-based health assessments. It offers blood-based assessments to monitor biomarkers in blood for evaluating individual’s risk for cancer, cardiovascular disease, diabetes and other chronic health conditions. The company is headquartered in Austin, TX. | Chairman | 31/07/2009 |
The EastWest Institute
 The EastWest Institute Miscellaneous Commercial ServicesCommercial Services The EastWest Institute operates as a network of influential stakeholders that engages in building trust and preventing conflict worldwide. The non-profit company is based in New York, NY. | Director/Board Member | 30/12/2009 |
Former positions of Mark B. Chandler
| Companies | Position | End |
|---|---|---|
| LUMINEX CORPORATION | Chief Executive Officer | 05/09/2002 |
| Inland Laboratories, Inc. | Founder | - |
Myriad RBM, Inc.
 Myriad RBM, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT. | Founder | 02/01/2012 |
Training of Mark B. Chandler
| The University of Texas at Austin | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Myriad RBM, Inc.
Myriad RBM, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad RBM, Inc. provides protein biomarker products and services. Its biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. The company was founded in 1998 and is headquartered in Salt Lake City, UT. | Commercial Services |
Biophysical Corp.
Biophysical Corp. BiotechnologyHealth Technology Biophysical Corp. develops, manages and markets biomarker-based health assessments. It offers blood-based assessments to monitor biomarkers in blood for evaluating individual’s risk for cancer, cardiovascular disease, diabetes and other chronic health conditions. The company is headquartered in Austin, TX. | Health Technology |
The EastWest Institute
The EastWest Institute Miscellaneous Commercial ServicesCommercial Services The EastWest Institute operates as a network of influential stakeholders that engages in building trust and preventing conflict worldwide. The non-profit company is based in New York, NY. | Commercial Services |
Luminex Corp.
 Luminex Corp. Medical SpecialtiesHealth Technology Luminex Corp. develops, manufactures and markets proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. The firm's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The company was founded by Mark B. Chandler and Van S. Chandler in May 1995 and is headquartered in Austin, TX. | Health Technology |
| Inland Laboratories, Inc. |
- Stock Market
- Insiders
- Mark B. Chandler
